What's Going On With Novavax (NVAX) Stock?

Novavax, Inc. NVAX shares are trading higher on Monday after the company announced an amendment to its Canada supply agreement, under which the Government of Canada will pay Novavax $349.6 million for forfeiting certain doses of its COVID vaccine. Additionally, the company announced the European Commission's full approval and marketing authorization of the company's COVID-19 vaccine, Nuvaxovid, on Thursday.

What To Know:

Novavax announced that it has amended its advanced purchase agreement with the Canadian government as of June 30. As part of the agreement, the Canadian government will pay Novavax a total of $349.6 million in two equal installments in 2023, compensating for previously forfeited vaccine doses. The first installment is due upon execution of the amendment, while the second installment is contingent upon the company's vaccine delivery in the latter half of 2023.

Despite the changes, the overall value of the original advanced purchase agreement remains unchanged. Novavax and the Canadian government also plan to expand their collaboration to provide health, economic, and pandemic preparedness benefits to Canada. 

What Else:

Novavax received the European Commission's full approval and marketing authorization for it's COVID-19 vaccine, Nuvaxovid, which can be marketing alongside approved vaccines from Pfizer PFE, Moderna MRNA, Janssen and AstraZeneca AZN in the European market. The protein-based vaccine is approved as a primary series for individuals aged 12 and older and as a booster for those aged 18 and older.

NVAX stock is rising on high trading volume with over 9.7 million shares already traded on Monday.  According to data from Benzinga Pro, the stock's 100-day average is 5.87 million shares. 

According to Fintel data, NVAX has outsized short interest with 37.86% of available shares currently being sold short. 

Related News: Why Mobilicom Stock Is Soaring Monday

NVAX Price Action: According to data from Benzinga Pro, Novavax shares are trading 17.6% higher at $8.50 at the time of publication.

Image: PhotoLizM from Pixabay